This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
respiratory syndrome | 2648 |
porcine reproductive | 2497 |
syndrome virus | 2152 |
prrsv infection | 676 |
immune response | 498 |
immune responses | 407 |
infected pigs | 352 |
infected cells | 295 |
virus infection | 281 |
virus replication | 260 |
prrsv replication | 254 |
type i | 253 |
viral rna | 230 |
prrsv nsp | 217 |
north american | 211 |
alveolar macrophages | 211 |
prrsv strain | 200 |
innate immune | 192 |
gene expression | 187 |
structural proteins | 178 |
prrsv strains | 177 |
influenza virus | 176 |
neutralizing antibodies | 172 |
highly pathogenic | 164 |
viral replication | 156 |
amino acid | 155 |
immune system | 150 |
rna viruses | 147 |
pigs infected | 145 |
porcine circovirus | 141 |
dendritic cells | 141 |
antiviral activity | 139 |
lelystad virus | 138 |
clinical signs | 133 |
nucleocapsid protein | 129 |
cell culture | 127 |
viral infection | 127 |
united states | 125 |
porcine respiratory | 124 |
mg ml | 123 |
equine arteritis | 122 |
arteritis virus | 121 |
present study | 119 |
adaptive immune | 118 |
porcine alveolar | 117 |
western blot | 115 |
respiratory disease | 114 |
rna virus | 110 |
antibody response | 109 |
structural protein | 109 |
nonstructural protein | 108 |
cord uid | 105 |
dub activity | 105 |
doc id | 105 |
vaccinated pigs | 102 |
lymph nodes | 102 |
porcine epidemic | 101 |
type prrsv | 101 |
time pcr | 100 |
well plates | 100 |
described previously | 99 |
prrsv rna | 98 |
prrs virus | 98 |
gp protein | 97 |
prrsv isolates | 97 |
innate immunity | 96 |
tcid ml | 95 |
i ifn | 94 |
circovirus type | 91 |
genomic rna | 91 |
amino acids | 91 |
total rna | 89 |
cell line | 88 |
open reading | 87 |
rna synthesis | 85 |
significantly higher | 85 |
control group | 84 |
viral infections | 83 |
protein expression | 83 |
pathogenic porcine | 83 |
cd cd | 82 |
previous studies | 82 |
three times | 82 |
lung lesions | 81 |
performed using | 81 |
swine influenza | 81 |
vero cells | 80 |
reproductive failure | 79 |
modified live | 79 |
viral proteins | 78 |
clinical disease | 78 |
oral fluid | 78 |
days post | 78 |
important role | 78 |
time rt | 78 |
swine industry | 77 |
tissue culture | 77 |
fever virus | 77 |
time points | 77 |
antibody titers | 76 |
transmissible gastroenteritis | 76 |
protective immunity | 75 |
previously described | 75 |
lactate dehydrogenase | 74 |
elevating virus | 74 |
host immune | 73 |
monoclonal antibody | 73 |
lipid rafts | 72 |
prrsv genome | 72 |
neutralizing antibody | 71 |
stranded rna | 71 |
challenged pigs | 71 |
strain vr | 71 |
control pigs | 70 |
viral genome | 70 |
serum samples | 70 |
interstitial pneumonia | 69 |
mm tris | 69 |
bovine serum | 69 |
lymphoid tissues | 68 |
treated cells | 68 |
dependent manner | 67 |
syndrome viruses | 67 |
virus entry | 66 |
statistically significant | 66 |
i interferon | 66 |
atcc vr | 66 |
swine infertility | 65 |
antibody responses | 65 |
room temperature | 65 |
diarrhea virus | 64 |
inhibitory effect | 64 |
prrsv vaccine | 64 |
expression levels | 64 |
family arteriviridae | 64 |
epidemic diarrhea | 64 |
pseudorabies virus | 63 |
epithelial cells | 63 |
nk cells | 62 |
significant differences | 62 |
cell responses | 62 |
immune cells | 62 |
respiratory coronavirus | 62 |
inflammatory cytokines | 61 |
acute respiratory | 61 |
proinflammatory cytokines | 61 |
dko pigs | 61 |
sg mrna | 61 |
results showed | 60 |
adaptive immunity | 60 |
viral loads | 60 |
respiratory tract | 59 |
virus vaccine | 59 |
persistent infection | 59 |
economic losses | 58 |
mycoplasma hyopneumoniae | 58 |
host cell | 58 |
nonstructural proteins | 58 |
negative control | 58 |
endoplasmic reticulum | 58 |
monoclonal antibodies | 58 |
ifn signaling | 58 |
swine fever | 57 |
rna polymerase | 57 |
strand rna | 57 |
gastroenteritis virus | 57 |
pam cultures | 57 |
genetic diversity | 57 |
gnotobiotic pigs | 57 |
cell lysates | 56 |
peripheral blood | 56 |
life cycle | 56 |
oral fluids | 56 |
severe acute | 56 |
disease virus | 56 |
lymph node | 55 |
prrsv gp | 55 |
kv adj | 55 |
infectious cdna | 54 |
reverse transcription | 54 |
per ml | 54 |
subgenomic mrna | 53 |
cells transfected | 53 |
additional file | 53 |
viral protein | 53 |
current study | 52 |
type porcine | 52 |
mm nacl | 52 |
cdna clone | 52 |
cell surface | 51 |
protective immune | 51 |
cells infected | 51 |
reading frames | 51 |
primary pams | 51 |
vaccine development | 50 |
porcine nidovirus | 50 |
order nidovirales | 50 |
signaling pathway | 50 |
like receptor | 50 |
target cells | 49 |
vaccinated animals | 49 |
goat anti | 49 |
experimental infection | 49 |
swine disease | 49 |
humoral immune | 49 |
virus strain | 49 |
economic impact | 49 |
analyzed using | 49 |
virus particles | 48 |
mononuclear cells | 48 |
host innate | 48 |
virus strains | 48 |
virus isolates | 48 |
isolate atcc | 48 |
plasma membrane | 48 |
infected animals | 48 |
differentially expressed | 48 |
infectious clone | 48 |
body weight | 47 |
significantly reduced | 47 |
lymphoid organs | 47 |
prrsv vaccines | 47 |
cell death | 46 |
prrsv antigens | 46 |
viral load | 46 |
mediated immune | 46 |
genbank accession | 46 |
secondary antibody | 46 |
blot analysis | 46 |
host cells | 45 |
prrsv isolate | 45 |
virus titers | 45 |
vaccine strain | 45 |
eav nsp | 45 |
positive cells | 45 |
vn antibodies | 44 |
maternal antibodies | 44 |
pathogenic prrsv | 44 |
gp fr | 44 |
hemorrhagic fever | 44 |
nuclear translocation | 44 |
north america | 44 |
prrsv infected | 44 |
prrsv helicase | 44 |
pigs vaccinated | 44 |
virus nucleocapsid | 43 |
inflammatory response | 43 |
signaling pathways | 43 |
prrsv may | 43 |
secreting cells | 43 |
previous study | 43 |
specific antibody | 43 |
like particles | 43 |
escherichia coli | 42 |
infected fetuses | 42 |
experimentally infected | 42 |
class i | 42 |
type ii | 42 |
significant difference | 42 |
significantly increased | 42 |
pam cells | 42 |
nucleic acid | 42 |
transcription factor | 42 |
atpase activity | 42 |
van reeth | 41 |
nb activation | 41 |
mystery swine | 41 |
simian hemorrhagic | 41 |
virus production | 41 |
inoculated pigs | 41 |
mouse igg | 41 |
significantly lower | 41 |
cellular cholesterol | 41 |
taken together | 41 |
field isolates | 41 |
cells expressing | 41 |
infected marc | 41 |
genome replication | 41 |
cl protease | 41 |
transfected cells | 41 |
virus porcine | 40 |
group pigs | 40 |
virus vaccines | 40 |
cd cells | 40 |
dependent rna | 40 |
culture supernatants | 40 |
syndrome coronavirus | 40 |
american type | 40 |
cytokine production | 40 |
orf gene | 40 |
mrna synthesis | 40 |
fetal bovine | 40 |
mtb wcl | 40 |
vaccinia virus | 39 |
molecular biology | 39 |
sequence analysis | 39 |
hela cells | 39 |
specific antibodies | 39 |
cleavage activity | 39 |
higher levels | 39 |
cell viability | 39 |
results indicated | 39 |
high levels | 39 |
nucleotide sequence | 39 |
determine whether | 39 |
highly conserved | 39 |
causative agent | 39 |
washed three | 39 |
envelope proteins | 38 |
reading frame | 38 |
crystal structure | 38 |
cell types | 38 |
time point | 38 |
infected pams | 38 |
among prrsv | 38 |
streptococcus suis | 38 |
classical swine | 38 |
lysis buffer | 38 |
cell response | 37 |
virus type | 37 |
virus neutralizing | 37 |
prrsv antigen | 37 |
viral clearance | 37 |
cellular immune | 37 |
even though | 37 |
sdd motif | 37 |
pcr products | 37 |
inactivated prrsv | 37 |
may also | 37 |
cell epitopes | 37 |
chimeric vlps | 36 |
live virus | 36 |
culture medium | 36 |
different prrsv | 36 |
copy numbers | 36 |
membrane protein | 36 |
transcript abundance | 36 |
pig groups | 36 |
independent experiments | 36 |
applied biosystems | 36 |
persistently infected | 36 |
marc cells | 36 |
mrna transcription | 36 |
medium containing | 35 |
determined using | 35 |
swine herds | 35 |
virus titer | 35 |
plp dub | 35 |
disease complex | 35 |
highly virulent | 35 |
isolator piglets | 35 |
i ifns | 35 |
prrsv proteins | 35 |
thermo fisher | 35 |
buffered saline | 35 |
washed twice | 35 |
cell activation | 34 |
santa cruz | 34 |
mouth disease | 34 |
signal transduction | 34 |
prrsv infections | 34 |
positive control | 34 |
derived dendritic | 34 |
blood mononuclear | 34 |
nsp protein | 34 |
european isolates | 34 |
fusion protein | 34 |
sybr green | 34 |
virus gp | 34 |
strain jxwn | 34 |
akt pathway | 34 |
proteolytic processing | 34 |
ng ml | 34 |
specific ifn | 34 |
porcine arterivirus | 33 |
immunodeficiency virus | 33 |
pigs inoculated | 33 |
endoribonuclease activity | 33 |
protein response | 33 |
sg mrnas | 33 |
virus nonstructural | 33 |
cysteine protease | 33 |
cells grown | 33 |
culture supernatant | 33 |
two different | 32 |
standard curve | 32 |
unfolded protein | 32 |
membrane cholesterol | 32 |
presenting cells | 32 |
dendritic cell | 32 |
sialic acid | 32 |
results suggest | 32 |
epidemic abortion | 32 |
heterologous prrsv | 32 |
virus infectivity | 32 |
mrna expression | 32 |
genetic variation | 32 |
sense rna | 32 |
pigs exposed | 32 |
experimental reproduction | 32 |
wt pigs | 32 |
cold pbs | 32 |
immune evasion | 31 |
pg ml | 31 |
high fever | 31 |
industry worldwide | 31 |
flow cytometry | 31 |
human immunodeficiency | 31 |
lung tissue | 31 |
respiratory signs | 31 |
life technologies | 31 |
following infection | 31 |
control animals | 31 |
mouse anti | 31 |
cell proliferation | 31 |
secondary bacterial | 31 |
quantitative real | 31 |
reverse transcriptase | 31 |
growing pigs | 31 |
infectious virus | 31 |
rabbit anti | 31 |
acute phase | 30 |
glycosylation sites | 30 |
statistical significance | 30 |
prrsv variants | 30 |
pregnant sows | 30 |
negative controls | 30 |
expressing prrsv | 30 |
data indicate | 30 |
european porcine | 30 |
envelope protein | 30 |
proteins encoded | 30 |
subgenomic mrnas | 30 |
equine influenza | 30 |
plant extracts | 30 |
nitric oxide | 30 |
dengue virus | 30 |
gp proteins | 30 |
american prrsv | 30 |
post infection | 30 |
reverse genetics | 30 |
cell lines | 30 |
based vaccine | 29 |
lung tissues | 29 |
nsp nsp | 29 |
three independent | 29 |
acid residues | 29 |
mhc class | 29 |
genes involved | 29 |
virus infections | 29 |
mucosal immune | 29 |
host response | 29 |
actinobacillus pleuropneumoniae | 29 |
porcine nidoviruses | 29 |
mrna levels | 29 |
viral titers | 29 |
culture plates | 29 |
inflammatory cytokine | 29 |
virus attachment | 29 |
cytopathic effect | 28 |
animal care | 28 |
results indicate | 28 |
prrsv challenge | 28 |
live porcine | 28 |
active site | 28 |
viral entry | 28 |
tb wcl | 28 |
mycobacterium tuberculosis | 28 |
virus genome | 28 |
fresh medium | 28 |
plasmid dna | 28 |
gp ecto | 28 |
alexa fluor | 28 |
mutant viruses | 28 |
recombinant baculovirus | 28 |
lung lesion | 28 |
critical role | 28 |
authors declare | 28 |
may play | 28 |
cholesterol depletion | 28 |
statistical analysis | 28 |
rna replication | 28 |
lymphoid tissue | 28 |
prrsv antibody | 28 |
herpes simplex | 28 |
prrs mlv | 28 |
cells treated | 28 |
mrna level | 28 |
partial protection | 28 |
per well | 27 |
luciferase reporter | 27 |
ifn production | 27 |
two groups | 27 |
calculated using | 27 |
binding protein | 27 |
glycyrrhizic acid | 27 |
monocytes macrophages | 27 |
proteolytic activity | 27 |
monkey kidney | 27 |
virus isolation | 27 |
arterivirus nsp | 27 |
specific mab | 27 |
vaccine virus | 27 |
infectious clones | 27 |
nk cell | 27 |
bacterial infections | 27 |
killed prrsv | 27 |
er stress | 27 |
i interferons | 27 |
atypical prrs | 27 |
ifn induction | 27 |
nidovirus infection | 27 |
lung homogenate | 27 |
prrsv orf | 27 |
virulent strain | 26 |
cells inoculated | 26 |
expressing gp | 26 |
different time | 26 |
cell cultures | 26 |
well plate | 26 |
lps administration | 26 |
growth kinetics | 26 |
igg antibody | 26 |
swine production | 26 |
igg antibodies | 26 |
vaccine efficacy | 26 |
early stage | 26 |
prrsv alone | 26 |
prrsv rjxwn | 26 |
prrsv plp | 26 |
measured using | 26 |
septal macrophages | 26 |
serine protease | 26 |
replication cycle | 26 |
prrsv genomic | 26 |
arterivirus replicase | 26 |
internal control | 26 |
porcine cd | 26 |
fisher scientific | 26 |
containing mm | 26 |
inhibit prrsv | 26 |
samples collected | 26 |
prrsv field | 26 |
bronchoalveolar lavage | 26 |
closely related | 26 |
results obtained | 26 |
cell population | 26 |
respiratory virus | 25 |
cov nsp | 25 |
key role | 25 |
western blotting | 25 |
also observed | 25 |
regulatory factor | 25 |
stomatitis virus | 25 |
ion channel | 25 |
pig model | 25 |
protease domain | 25 |
dnase i | 25 |
horseradish peroxidase | 25 |
american strains | 25 |
plaque assay | 25 |
alpha beta | 25 |
acid sequence | 25 |
another study | 25 |
enhanced replication | 25 |
pp ab | 25 |
length cdna | 25 |
cellular proteins | 25 |
european genotype | 25 |
virus comparison | 25 |
hcl ph | 25 |
virus rna | 25 |
plasma cells | 25 |
kag vaccine | 25 |
antiviral effect | 25 |
also known | 25 |
situ hybridization | 25 |
gp ectodomain | 25 |
nested set | 25 |
vesicular stomatitis | 25 |
cell membrane | 25 |
cdna clones | 25 |
terminal region | 25 |
mammalian cells | 25 |
intranasal delivery | 25 |
nsp mutants | 24 |
pigs compared | 24 |
syncytial virus | 24 |
parental virus | 24 |
coding region | 24 |
state university | 24 |
virulent strains | 24 |
coding regions | 24 |
vn titers | 24 |
infectious bronchitis | 24 |
viral pathogens | 24 |
hepatitis virus | 24 |
den boon | 24 |
based vaccines | 24 |
simplex virus | 24 |
secondary infections | 24 |
th cells | 24 |
stimulated genes | 24 |
infectious agents | 24 |
necrosis factor | 24 |
pedv infection | 24 |
porcine ifn | 24 |
rna genome | 24 |
viral genomic | 24 |
rna recombination | 24 |
nuclear localization | 24 |
ge healthcare | 24 |
prrsv infectivity | 24 |
progeny virus | 24 |
kindly provided | 24 |
two major | 24 |
significantly inhibited | 24 |
respiratory syncytial | 24 |
accession number | 24 |
knu cells | 24 |
interferon regulatory | 24 |
linked immunosorbent | 24 |
coding sequence | 24 |
significant economic | 24 |
dmem containing | 24 |
inhibited prrsv | 23 |
pcr product | 23 |
leader sequence | 23 |
plasmacytoid dendritic | 23 |
iga antibodies | 23 |
prrsv challenged | 23 |
inflammatory responses | 23 |
primers used | 23 |
better understanding | 23 |
pcr amplification | 23 |
sf cells | 23 |
significant increase | 23 |
acute infection | 23 |
european prrsv | 23 |
day post | 23 |
prrsv infectious | 23 |
reproductive syndrome | 23 |
viral titer | 23 |
recent studies | 23 |
oxidative stress | 23 |
commercial vaccines | 23 |
live vaccine | 23 |
viral envelope | 23 |
specific group | 23 |
pfu ml | 23 |
cellular membrane | 23 |
natural killer | 23 |
differential expression | 23 |
virus characterization | 23 |
virus induces | 23 |
hek cells | 23 |
sequence identity | 23 |
blood samples | 23 |
respiratory distress | 23 |
viral antigen | 23 |
directed mutagenesis | 23 |
virulent prrsv | 23 |
nendou activity | 22 |
van dinten | 22 |
immunized animals | 22 |
virus nsp | 22 |
five times | 22 |
neonatal pigs | 22 |
chinese highly | 22 |
prrsv specific | 22 |
control cells | 22 |
cd expression | 22 |
immunosorbent assay | 22 |
protein kinase | 22 |
conjugated goat | 22 |
trizol reagent | 22 |
polyubiquitin chains | 22 |
antibody production | 22 |
mediated immunity | 22 |
prrsv vr | 22 |
cell populations | 22 |
us porcine | 22 |
antigen presentation | 22 |
alveolar macrophage | 22 |
passive transfer | 22 |
irf activation | 22 |
economically important | 22 |
antiviral response | 22 |
neutralizing activity | 22 |
conventional pigs | 22 |
protein levels | 22 |
cytokine responses | 22 |
prrsv clpro | 22 |
attenuated prrsv | 22 |
adjuvanted np | 22 |
like protease | 22 |
pcr assay | 22 |
intravascular macrophages | 22 |
bronchitis virus | 22 |
respiratory diseases | 22 |
vaccine delivery | 22 |
many viruses | 22 |
humoral response | 22 |
poorly understood | 22 |
dual infections | 21 |
body temperature | 21 |
performed according | 21 |
prrsv pathogenesis | 21 |
chimeric virus | 21 |
passive immunity | 21 |
culture infectious | 21 |
exposed pigs | 21 |
chain reaction | 21 |
well tissue | 21 |
field conditions | 21 |
human coronavirus | 21 |
ex vivo | 21 |
res doi | 21 |
serum albumin | 21 |
infectious diseases | 21 |
log tcid | 21 |
two continents | 21 |
nsp inhibits | 21 |
lung damage | 21 |
unparalleled outbreaks | 21 |
fold change | 21 |
porcine macrophages | 21 |
regulated genes | 21 |
crl cells | 21 |
previous reports | 21 |
dependent enhancement | 21 |
taqman probe | 21 |
mock infected | 21 |
infected piglets | 21 |
tracheobronchial lymph | 21 |
high mortality | 21 |
day pi | 21 |
nucleic acids | 21 |
cell lysate | 21 |
tissue samples | 21 |
porcine parvovirus | 21 |
prrsv entry | 21 |
pigs porcine | 21 |
containing fbs | 21 |
membrane proteins | 21 |
natural infection | 21 |
arterivirus replication | 21 |
specific immune | 21 |
infl uenza | 21 |
conserved among | 21 |
investigate whether | 21 |
generated using | 21 |
primer pairs | 21 |
scavenger receptor | 21 |
considered statistically | 20 |
animal health | 20 |
among different | 20 |
unique hallmark | 20 |
study showed | 20 |
cell monolayers | 20 |
human rotavirus | 20 |
purified using | 20 |
bd biosciences | 20 |
subgenomic rnas | 20 |
serially diluted | 20 |
cells cultured | 20 |
nb pathway | 20 |
pigs persistently | 20 |
empty vector | 20 |
virus challenge | 20 |
delivery systems | 20 |
mlv vaccine | 20 |
pigs showed | 20 |
thai medicinal | 20 |
prrsv titers | 20 |
interferon signaling | 20 |
weeks post | 20 |
signalling pathway | 20 |
graphpad prism | 20 |
bal fluid | 20 |
foreign gene | 20 |
control prrsv | 20 |
veterinary medicine | 20 |
immune dysregulation | 20 |
molecular cloning | 20 |
homogeneous subpopulation | 20 |
specific igg | 20 |
fatal prrsv | 20 |
cells using | 20 |
pulmonary alveolar | 20 |
final concentration | 20 |
virus yield | 20 |
gdd motif | 20 |
complement activation | 20 |
previously reported | 20 |
large white | 20 |
genotype prrsv | 20 |
increased expression | 20 |
also found | 20 |
prrsv activity | 20 |
culture media | 20 |
protective efficacy | 20 |
molecular dissection | 20 |
data suggest | 20 |
virus neutralization | 20 |
polymerase chain | 20 |
per group | 20 |
permissive cells | 20 |
whole cell | 20 |
lung parenchyma | 20 |
expression vector | 20 |
prrs vaccine | 20 |
viral particles | 20 |
ros production | 20 |
body junction | 20 |
recombinant prrsv | 20 |
cell signaling | 19 |
spontaneous mutations | 19 |
prrsv nucleocapsid | 19 |
wt nsp | 19 |
mucosal immunity | 19 |
pigs experimentally | 19 |
cells per | 19 |
specific pathogen | 19 |
based real | 19 |
heterologous gene | 19 |
deletion mutants | 19 |
prrsv olot | 19 |
pdcov infection | 19 |
african swine | 19 |
potent adjuvant | 19 |
derived macrophages | 19 |
following prrsv | 19 |
expression system | 19 |
antibody levels | 19 |
prrsv sequences | 19 |
localization signal | 19 |
membrane vesicles | 19 |
beta interferon | 19 |
pbs containing | 19 |
infectious dose | 19 |
coronavirus nsp | 19 |
type nsp | 19 |
secondary structure | 19 |
humoral immunity | 19 |
reverse primer | 19 |
significant reduction | 19 |
nsp proteins | 19 |
commercially available | 19 |
viral diseases | 19 |
two genotypes | 19 |
african green | 19 |
gp ep | 19 |
antigen presenting | 19 |
firefly luciferase | 19 |
insect cells | 19 |
gp gp | 19 |
young pigs | 19 |
virus date | 19 |
live vaccines | 19 |
dna sequencing | 19 |
green monkey | 19 |
different times | 19 |
using lipofectamine | 19 |
prrsv mn | 19 |
targeting nsp | 19 |
polyclonal antibody | 19 |
viral life | 19 |
protein synthesis | 19 |
molecular characterization | 19 |
severe disease | 19 |
experimental conditions | 19 |
divergent evolution | 19 |
inhibits prrsv | 19 |
antiviral activities | 19 |
gel electrophoresis | 19 |
pcr assays | 19 |
recent study | 19 |
new order | 19 |
challenge infection | 19 |
immunofluorescence assay | 19 |
several studies | 19 |
bone marrow | 18 |
selective pressure | 18 |
bacterial pathogens | 18 |
histocompatibility complex | 18 |
tmp peptide | 18 |
iga antibody | 18 |
data obtained | 18 |
inhibits porcine | 18 |
prrsv inoculation | 18 |
supporting information | 18 |
current knowledge | 18 |
immunological responses | 18 |
expression profiles | 18 |
na gp | 18 |
rabbit igg | 18 |
american isolates | 18 |
copy number | 18 |
prrs viruses | 18 |
microscopic lung | 18 |
cdna synthesis | 18 |
mutational analysis | 18 |
electron microscopy | 18 |
wild type | 18 |
lavage fluid | 18 |
protein coding | 18 |
producing cells | 18 |
major envelope | 18 |
differential production | 18 |
pcr using | 18 |
prrsv particles | 18 |
data indicated | 18 |
agarose gel | 18 |
second lps | 18 |
expression plasmids | 18 |
rtgev vectors | 18 |
arteriviridae family | 18 |
porcine monocyte | 18 |
inhibit ifn | 18 |
san diego | 18 |
dually infected | 18 |
comprising coronaviridae | 18 |
four pigs | 18 |
order comprising | 18 |
genomic cdna | 18 |
nsp gene | 18 |
error bars | 18 |
significantly decreased | 18 |
infected cell | 18 |
co incubator | 18 |
lesion scores | 18 |
recombination events | 18 |
cleavage site | 18 |
monitored daily | 18 |
recombinant proteins | 18 |
rna extraction | 18 |
binding activity | 18 |
major histocompatibility | 18 |
different strains | 18 |
poly i | 18 |
significantly elevated | 18 |
luciferase activity | 18 |
untranslated region | 18 |
mini kit | 18 |
fluorescence microscope | 18 |
exogenous cholesterol | 18 |
stat stat | 18 |
standard deviations | 18 |
since prrsv | 18 |
like receptors | 18 |
infectious prrsv | 17 |
ctl epitopes | 17 |
protein encoded | 17 |
american strain | 17 |
contact pigs | 17 |
vn antibody | 17 |
mutant virus | 17 |
widely used | 17 |
broadly neutralizing | 17 |
recombinant porcine | 17 |
old pigs | 17 |
encephalitis virus | 17 |
mouse hepatitis | 17 |
naturally infected | 17 |
primary antibody | 17 |
indirect immunofluorescence | 17 |
fluid samples | 17 |
tcid per | 17 |
infected groups | 17 |
differences among | 17 |
results demonstrated | 17 |
induced apoptosis | 17 |
prrsv antibodies | 17 |
lung viral | 17 |
live prrsv | 17 |
jak stat | 17 |
quantitative rt | 17 |
immune cell | 17 |
using trizol | 17 |
oxyanion hole | 17 |
vaccinated groups | 17 |
antiviral effects | 17 |
hypervariable region | 17 |
pcr analysis | 17 |
interferon production | 17 |
bal cells | 17 |
genotype i | 17 |
catalytic activity | 17 |
deep sequencing | 17 |
cytokine levels | 17 |
rna isolation | 17 |
one pig | 17 |
producing countries | 17 |
three groups | 17 |
cleavage sites | 17 |
indicated times | 17 |
host responses | 17 |
cell cytotoxicity | 17 |
fusion proteins | 17 |
clinical symptoms | 17 |
molecular weight | 17 |
sterilizing immunity | 17 |
japanese encephalitis | 17 |
viral challenge | 17 |
compare lanes | 17 |
investigated whether | 17 |
small intestine | 17 |
go terms | 17 |
pig lungs | 17 |
obtained using | 17 |
replication complex | 17 |
wt group | 17 |
complete genome | 17 |
data presented | 17 |
tl co | 17 |
transmembrane proteins | 17 |
inactivated vaccine | 17 |
st cells | 17 |
conjugated anti | 17 |
antibody repertoire | 17 |
infected macrophages | 16 |
forward primer | 16 |
respiratory viral | 16 |
myeloid cells | 16 |
virus challenged | 16 |
virus titre | 16 |
mucosal surfaces | 16 |
novel structural | 16 |
mean group | 16 |
prrsv replicase | 16 |
influenza viruses | 16 |
start codon | 16 |
nsp tf | 16 |
barr virus | 16 |
heterologous challenge | 16 |
buffered formalin | 16 |
vaccine induced | 16 |
thymic atrophy | 16 |
total number | 16 |
three different | 16 |
master mix | 16 |
time quantitative | 16 |
pigs coinfected | 16 |
virus encoded | 16 |
expression plasmid | 16 |
type iii | 16 |
linked glycosylation | 16 |
simultaneous detection | 16 |
heterologous genes | 16 |
microscopic lesions | 16 |
binding domain | 16 |
prrsv genotypes | 16 |
prrsv proliferation | 16 |
inhibits ifn | 16 |
main proteinase | 16 |
derived vectors | 16 |
vivo studies | 16 |
analysis revealed | 16 |
decoy epitope | 16 |
pulmonary intravascular | 16 |
dual infection | 16 |
cell tropism | 16 |
future studies | 16 |
sendai virus | 16 |
randomly assigned | 16 |
infectious disease | 16 |
linked polyubiquitin | 16 |
junction sites | 16 |
mosaic vaccine | 16 |
knockout pigs | 16 |
cell cycle | 16 |
statistical analyses | 16 |
field strains | 16 |
van marle | 16 |
dna polymerase | 16 |
high morbidity | 16 |
restriction sites | 16 |
evaluated using | 16 |
strain wuh | 16 |
terminal domain | 16 |
two large | 16 |
virus yields | 16 |
mm edta | 15 |
pedv clpro | 15 |
morpholino oligomers | 15 |
green i | 15 |
prrsv virus | 15 |
use committee | 15 |
heat shock | 15 |
reporter assay | 15 |
quantitative pcr | 15 |
mlv mtb | 15 |
neutralizing epitopes | 15 |
positive strand | 15 |
supplementary material | 15 |
lipid metabolism | 15 |
large number | 15 |
molecular epidemiology | 15 |
sasa quelpaertensis | 15 |
prrsv nsps | 15 |
class ii | 15 |
expressing cells | 15 |
swine arterivirus | 15 |
science foundation | 15 |
ha antibody | 15 |
may provide | 15 |
pregnant gilts | 15 |
immune signalling | 15 |
signal sequence | 15 |
nucleotide sequencing | 15 |
phylogenetic analysis | 15 |
nidovirus replication | 15 |
receptor cd | 15 |
glycosylation site | 15 |
virulent rv | 15 |
severe clinical | 15 |
umbilical cord | 15 |
vet res | 15 |
standard error | 15 |
individual pigs | 15 |
pcr system | 15 |
catalytic domain | 15 |
similar results | 15 |
respiratory symptoms | 15 |
expressed proteins | 15 |
fluorescent protein | 15 |
vaccines based | 15 |
ifn response | 15 |
atg proteins | 15 |
prrsv group | 15 |
like particle | 15 |
nsp junction | 15 |
control prrs | 15 |
lc puncta | 15 |
different viral | 15 |
edited pigs | 15 |
cells well | 15 |
european strains | 15 |
serum neutralization | 15 |
i molecules | 15 |
infected group | 15 |
capsid protein | 15 |
pigs naturally | 15 |
two distinct | 15 |
serial dilutions | 15 |
inactivated virus | 15 |
treatment groups | 15 |
free dmem | 15 |
repertoire development | 15 |
nuclear factor | 15 |
using graphpad | 15 |
field strain | 15 |
negative strands | 15 |
remains unclear | 15 |
gp expression | 15 |
systemic immune | 15 |
weight gain | 15 |
envelope glycoprotein | 15 |
prrsv also | 15 |
medicinal plant | 15 |
nucleolar localization | 15 |
eastern europe | 15 |
secondary lymphoid | 15 |
primer pair | 15 |
cell entry | 15 |
rna levels | 15 |
minor envelope | 15 |
expression level | 15 |
prrsv persistence | 15 |
low levels | 15 |
replicase orf | 15 |
ebola virus | 15 |
visualized using | 15 |
indicated time | 14 |
mediated innate | 14 |
virus titres | 14 |
hydrogen bonds | 14 |
rectal temperature | 14 |
monocyte macrophage | 14 |
pathogenic strain | 14 |
ovarian tumor | 14 |
may explain | 14 |
plga nanoparticle | 14 |
healthy pigs | 14 |
canine parvovirus | 14 |
lg ml | 14 |
membrane permeability | 14 |
cellular responses | 14 |
transcription factors | 14 |
ng well | 14 |
tumor necrosis | 14 |
i ubiquitination | 14 |
porcine high | 14 |
genetically divergent | 14 |
infects monocyte | 14 |
sodium dodecyl | 14 |
recombinant vaccinia | 14 |
natural science | 14 |
expressed genes | 14 |
mm sodium | 14 |
assay kit | 14 |
largest rna | 14 |
results provide | 14 |
prrsv type | 14 |
co hb | 14 |
stimulated gene | 14 |
current status | 14 |
analysis using | 14 |
coli bl | 14 |
significantly different | 14 |
fold dilutions | 14 |
results demonstrate | 14 |
pulmonary lesions | 14 |
gp fusion | 14 |
points post | 14 |
stranded positive | 14 |
interferon alpha | 14 |
live attenuated | 14 |
crucial role | 14 |
sham inoculated | 14 |
high virulence | 14 |
data analysis | 14 |
studies using | 14 |
prrs immunology | 14 |
viral disease | 14 |
plasmids expressing | 14 |
measles virus | 14 |
data collection | 14 |
control sirna | 14 |
important roles | 14 |
tagged nsp | 14 |
antiviral responses | 14 |
different cell | 14 |
subunit vaccines | 14 |
cell differentiation | 14 |
lps exposed | 14 |
infected porcine | 14 |
rna copies | 14 |
lung injury | 14 |
macrophage lineage | 14 |
neonatal piglets | 14 |
technical assistance | 14 |
bordetella bronchiseptica | 14 |
viral pathogenesis | 14 |
porcine viral | 14 |
ingelvac prrs | 14 |
cell survival | 14 |
vaccine candidate | 14 |
emerging viruses | 14 |
gene products | 14 |
sars coronavirus | 14 |
porcine lung | 14 |
cmv promoter | 14 |
prrsv load | 14 |
suis serotype | 14 |
wide range | 14 |
control groups | 14 |
glycan shielding | 14 |
results suggested | 14 |
prrsv structural | 14 |
bacterial infection | 14 |
reduced prrsv | 14 |
studies showed | 14 |
mucosal sites | 14 |
cleavage assay | 14 |
also showed | 14 |
like proteases | 14 |
considered positive | 14 |
virus inhibits | 14 |
source data | 14 |
pork industry | 14 |
previous report | 14 |
pathogen interactions | 14 |
piglets infected | 14 |
real time | 14 |
following vaccination | 14 |
likely due | 14 |
utero infection | 14 |
rna level | 14 |
virus load | 14 |
genomic sequence | 14 |
observed among | 14 |
recombinant protein | 14 |
point mutation | 14 |
mouse model | 14 |
rectal temperatures | 14 |
neutralizing epitope | 14 |
lung mnc | 14 |
field isolate | 14 |
like serine | 14 |
weaned pigs | 13 |
foreign genes | 13 |
strain respprrs | 13 |
specific primers | 13 |
blood monocytes | 13 |
humidified co | 13 |
primary antibodies | 13 |
th response | 13 |
nuclear export | 13 |
green fluorescent | 13 |
virus release | 13 |
dna binding | 13 |
prrsv appears | 13 |
reverse transcribed | 13 |
pig serum | 13 |
functional properties | 13 |
point mutations | 13 |
cell subsets | 13 |
viral infectivity | 13 |
orf sequences | 13 |
viral rnas | 13 |
experimental groups | 13 |
virus belonging | 13 |
virus inoculation | 13 |
target sites | 13 |
virus stocks | 13 |
gross lung | 13 |
rna copy | 13 |
srcr domain | 13 |
american genotype | 13 |
whether prrsv | 13 |
expression vectors | 13 |
microbiol doi | 13 |
porcine deltacoronavirus | 13 |
increased frequency | 13 |
three pigs | 13 |
mucosal vaccines | 13 |
online version | 13 |
washed five | 13 |
mutant nsp | 13 |
arterivirus group | 13 |
inhibitory effects | 13 |
buffer containing | 13 |
acid changes | 13 |
may affect | 13 |
replicative endoribonuclease | 13 |
virus titration | 13 |
current vaccines | 13 |
vectors expressing | 13 |
confluent marc | 13 |
late gestation | 13 |
protein concentration | 13 |
plga nps | 13 |
entry process | 13 |
recombinant strains | 13 |
transcription complex | 13 |
sappan extract | 13 |
receptor signaling | 13 |
glycoprotein gp | 13 |
agricultural university | 13 |
vsv vrp | 13 |
nuclear import | 13 |
pivotal role | 13 |
virus isolate | 13 |
specific rt | 13 |
pig industry | 13 |
prrs outbreaks | 13 |
probably due | 13 |
viral antigens | 13 |
prrsv yield | 13 |
inactivated vaccines | 13 |
isolate vr | 13 |
cruz biotechnology | 13 |
fresh dmem | 13 |
kag vaccinated | 13 |
regulatory cells | 13 |
cell epitope | 13 |
comparative pathogenicity | 13 |
virus structural | 13 |
uninfected cells | 13 |
mm dtt | 13 |
virus shedding | 13 |
effective vaccines | 13 |
facs buffer | 13 |
pigs receiving | 13 |
gp cells | 13 |
vaccine strains | 13 |
macroscopic lung | 13 |
cellular immunity | 13 |
mediated endocytosis | 13 |
apoptotic genes | 13 |
virulent heterologous | 13 |
gpi modification | 13 |
dna vaccination | 13 |
sequence alignment | 13 |
elispot assay | 13 |
respiratory pathogens | 13 |
supplementary table | 13 |
using prrsv | 13 |
considered significant | 13 |
th th | 13 |
nsp may | 13 |
immunized pigs | 13 |
cis cleavage | 13 |
secondary infection | 13 |
binding site | 13 |
tissue damage | 13 |
nsp region | 13 |
virulent porcine | 13 |
vitro interferon | 13 |
viral membrane | 13 |
associated lymphoid | 13 |
fluorescent signal | 13 |
pulmonary function | 13 |
reporter plasmid | 13 |
antigenic differences | 13 |
lower panels | 13 |
days later | 13 |
study demonstrated | 13 |
van gorp | 13 |
conventional piglets | 13 |
dmem supplemented | 13 |
induces apoptosis | 13 |
anchored proteins | 13 |
persistent infections | 13 |
nsp also | 13 |
wasting syndrome | 13 |
zna probe | 13 |
cytokine receptor | 13 |
chimeric viruses | 13 |
better understand | 12 |
dodecyl sulfate | 12 |
early stages | 12 |
murine coronavirus | 12 |
detected using | 12 |
heterologous virus | 12 |
nasal swabs | 12 |
plc digestion | 12 |
attenuated virus | 12 |
authors read | 12 |
mucosal immunization | 12 |
affect viral | 12 |
times greater | 12 |
pig farms | 12 |
cholesterol content | 12 |
confer protection | 12 |
polyclonal activation | 12 |
equal volume | 12 |
multisystemic wasting | 12 |
killed virus | 12 |
cleavage products | 12 |
states pork | 12 |
phosphate dehydrogenase | 12 |
freshly isolated | 12 |
lesser extent | 12 |
attenuated rv | 12 |
porcine viruses | 12 |
virus specific | 12 |
interferon antagonism | 12 |
dependent mechanism | 12 |
structural biology | 12 |
virus emerging | 12 |
structural basis | 12 |
natural host | 12 |
rna helicase | 12 |
findings indicate | 12 |
inactivated porcine | 12 |
molecular mass | 12 |
kg body | 12 |
local immune | 12 |
arterivirus molecular | 12 |
ag vaccinated | 12 |
protein genes | 12 |
ml ifn | 12 |
replicase proteins | 12 |
reactive oxygen | 12 |
different concentrations | 12 |
prrsv replicates | 12 |
junction sequence | 12 |
final manuscript | 12 |
strand cdna | 12 |
acute prrs | 12 |
infected swine | 12 |
cell mediated | 12 |
detectable levels | 12 |
reticulum stress | 12 |
distilled water | 12 |
intestinal iga | 12 |
adhesion molecules | 12 |
way anova | 12 |
pork producers | 12 |
ml penicillin | 12 |
total protein | 12 |
like proteinase | 12 |
orf protein | 12 |
oxygen species | 12 |
alpha response | 12 |
body trs | 12 |
inhibiting prrsv | 12 |
domestic animals | 12 |
two independent | 12 |
standard deviation | 12 |
cellular receptor | 12 |
cells via | 12 |
influenza vaccine | 12 |
pcv antigen | 12 |
swine sera | 12 |
mouse monoclonal | 12 |
thank dr | 12 |
antibody conjugated | 12 |
structural genes | 12 |
inoculated controls | 12 |
sus scrofa | 12 |
ion channels | 12 |
kidney cell | 12 |
inclusion bodies | 12 |
protein domains | 12 |
immunoperoxidase monolayer | 12 |
monolayer assay | 12 |
signaling technology | 12 |
cell exhaustion | 12 |
antiviral immune | 12 |
major structural | 12 |
prrsv aprrs | 12 |
inducible gene | 12 |
two us | 12 |
viral strain | 12 |
reduced lung | 12 |
well documented | 12 |
reported previously | 12 |
tritrichomonas foetus | 12 |
protein may | 12 |
molecular mechanisms | 12 |
binding sites | 12 |
lipid raft | 12 |
new insights | 12 |
virus using | 12 |
medium supplemented | 12 |
different virulence | 12 |
replicase polyproteins | 12 |
supplementary file | 12 |
pig lung | 12 |
american porcine | 12 |
cell adhesion | 12 |
nsp expression | 12 |
one day | 12 |
prototype strain | 12 |
mediated cytotoxicity | 12 |
blood cells | 12 |
envelope glycoproteins | 12 |
viral respiratory | 12 |
coding sequences | 12 |
viral genes | 12 |
first week | 12 |
autophagosomes induced | 12 |
recombinant virus | 12 |
institutional animal | 12 |
quelpaertensis nakai | 12 |
different respiratory | 12 |
exact test | 12 |
cultured cells | 12 |
cd foxp | 12 |
amniotic fluid | 12 |
macrophage activation | 12 |
protein inhibits | 12 |
induce apoptosis | 12 |
dna vaccine | 12 |
asymptomatic pigs | 12 |
virus clearance | 12 |
induced immunosuppression | 12 |
previous work | 12 |
disease caused | 12 |
stat signaling | 12 |
cd knockout | 12 |
lung pathology | 12 |
hev infection | 12 |
us prrsv | 12 |
complement system | 12 |
sf sr | 12 |
primer sequences | 12 |
described elsewhere | 12 |
antibodies specific | 12 |
pma treatment | 12 |
plp cis | 12 |
peptide epitopes | 12 |
crispr cas | 12 |
small envelope | 12 |
translation initiation | 12 |
indicated antibodies | 12 |
encoded proteinases | 12 |
virus ns | 12 |
gene delivery | 12 |
relatively low | 12 |
parental strains | 12 |
national natural | 12 |
virus viability | 12 |
protein translation | 12 |
recognition receptors | 12 |
prrsv clsp | 12 |
enrichment analyses | 12 |
virus pathogenesis | 11 |
amersham biosciences | 11 |
lactogenic immunity | 11 |
conducted using | 11 |
antigenic diversity | 11 |
within orf | 11 |
loading control | 11 |
supporting loop | 11 |
economic loss | 11 |
rpmi medium | 11 |
immune systems | 11 |
human daf | 11 |
feeder pigs | 11 |
upregulation expression | 11 |
vaccine candidates | 11 |
vitro studies | 11 |
anchored protein | 11 |
liquid nitrogen | 11 |
remained unchanged | 11 |
mhv nsp | 11 |
virol doi | 11 |
serum sample | 11 |
grand island | 11 |
optical density | 11 |
vice versa | 11 |
cell type | 11 |
serum antibodies | 11 |
diagnostic laboratory | 11 |
pigs also | 11 |
untreated cells | 11 |
two prrsv | 11 |
pigs immunized | 11 |
uninfected control | 11 |
pedv replication | 11 |
cell numbers | 11 |
cmi response | 11 |
high frequency | 11 |
restriction fragment | 11 |
pathogen free | 11 |
vaccine design | 11 |
reproductive tract | 11 |
highly variable | 11 |
highly permissive | 11 |
boehringer ingelheim | 11 |
ha protein | 11 |
growth factor | 11 |
zinc finger | 11 |
recovered viruses | 11 |
phylogenetic tree | 11 |
studies demonstrated | 11 |
common mucosal | 11 |
cell development | 11 |
biological processes | 11 |
different lineages | 11 |
ppmo treatment | 11 |
coronavirus replication | 11 |
zn levels | 11 |
etiological agent | 11 |
pattern recognition | 11 |
nucleotide changes | 11 |
fixed cells | 11 |
lymphocyte proliferation | 11 |
reaction mixture | 11 |
highly effective | 11 |
pcv dna | 11 |
graphpad software | 11 |
sodium azide | 11 |
terminal deletion | 11 |
virus identification | 11 |
times post | 11 |
ripa buffer | 11 |
total cellular | 11 |
co atmosphere | 11 |
virus followed | 11 |
prrsv virion | 11 |
swine infl | 11 |
per pig | 11 |
veterinary vaccines | 11 |
interstitial macrophages | 11 |
inhibits type | 11 |
porcine immune | 11 |
viral particle | 11 |
antibodies directed | 11 |
phosphorylated stat | 11 |
host defense | 11 |
constructed using | 11 |
plasmid encoding | 11 |
important diseases | 11 |
nonneutralizing epitopes | 11 |
vectored vaccines | 11 |
induced pneumonia | 11 |
subgenomic rna | 11 |
findings suggest | 11 |
fluorescence intensity | 11 |
severe reproductive | 11 |
viruses may | 11 |
common leader | 11 |
pigs challenged | 11 |
vaccine antigens | 11 |
passive protection | 11 |
protein assay | 11 |
mn challenged | 11 |
also demonstrated | 11 |
sqe treatment | 11 |
challenge study | 11 |
length genome | 11 |
mlv nsp | 11 |
newborn piglets | 11 |
intriguing set | 11 |
false discovery | 11 |
gastroenteritis coronavirus | 11 |
prrsv induces | 11 |
infected dams | 11 |
pig production | 11 |
specific monoclonal | 11 |
sgrna synthesis | 11 |
biological properties | 11 |
nsp serine | 11 |
rabbit antiserum | 11 |
molecular mimicry | 11 |
data showed | 11 |
inhibitory siglec | 11 |
nervous system | 11 |
stably expressing | 11 |
different mechanisms | 11 |
protein degradation | 11 |
west nile | 11 |
well established | 11 |
also identified | 11 |
antiviral immunity | 11 |
fragment length | 11 |
encephalomyocarditis virus | 11 |
cytokine expression | 11 |
lena strain | 11 |
attenuated vaccine | 11 |
raw data | 11 |
inoculated animals | 11 |
approximately kb | 11 |
bal fluids | 11 |
i prrsv | 11 |
neutralization epitope | 11 |
cell receptor | 11 |
tested whether | 11 |
final concentrations | 11 |
high level | 11 |
tcid assay | 11 |
complex interactions | 11 |
also shown | 11 |
interferon gamma | 11 |
laboratory animal | 11 |
might also | 11 |
receptor expression | 11 |
prrsv immunity | 11 |
haemophilus parasuis | 11 |
lymphoid hyperplasia | 11 |
mm mgcl | 11 |
alternative orf | 11 |
coronavirus nucleocapsid | 11 |
like prrsv | 11 |
cytokines measured | 11 |
induce neutralizing | 11 |
may represent | 11 |
activated protein | 11 |
treated control | 11 |
pdb code | 11 |
potent antiviral | 11 |
discovery rate | 11 |
deionized water | 11 |
inoculated onto | 11 |
data show | 11 |
cellular components | 11 |
tumour necrosis | 11 |
genomic dna | 10 |
various concentrations | 10 |
infected lungs | 10 |
european subtype | 10 |
rapid detection | 10 |
kidney cells | 10 |
terminal residues | 10 |
management practices | 10 |
qiaamp viral | 10 |
negatively charged | 10 |
replication transcription | 10 |
sequence data | 10 |
strain mn | 10 |
cell immune | 10 |
cell frequency | 10 |
south korea | 10 |
deletion mutant | 10 |
transfection reagent | 10 |
nile virus | 10 |
antiviral properties | 10 |
irf phosphorylation | 10 |
induced ifn | 10 |
single stranded | 10 |
mandibular lymph | 10 |
stop codon | 10 |
ii prrsv | 10 |
antiviral agents | 10 |
using anti | 10 |
genetics system | 10 |
european type | 10 |
vet microbiol | 10 |
using real | 10 |
important viral | 10 |
eagle medium | 10 |
million annually | 10 |
vaccine formulation | 10 |
genetic heterogeneity | 10 |
immunized group | 10 |
tissue sections | 10 |
matrix protein | 10 |
heterologous protection | 10 |
prrsv envelope | 10 |
two strains | 10 |
significant effect | 10 |
cell pellets | 10 |
respiratory system | 10 |
animals inoculated | 10 |
antiviral defense | 10 |
positive farms | 10 |
cytokine response | 10 |
evasion strategies | 10 |
enveloped viruses | 10 |
luciferase activities | 10 |
also detected | 10 |
copies per | 10 |
old cesarean | 10 |
host defenses | 10 |
endothelial cells | 10 |
may result | 10 |
laboratory animals | 10 |
virus infected | 10 |
cellular rna | 10 |
atp substrate | 10 |
distinct genotypes | 10 |
novel antiviral | 10 |
higher amounts | 10 |
orf sequence | 10 |
jurisdictional claims | 10 |
strains vr | 10 |
following experimental | 10 |
protein complex | 10 |
total rnas | 10 |
human cytomegalovirus | 10 |
target genes | 10 |
states porcine | 10 |
fever syndrome | 10 |
first detected | 10 |
specific cd | 10 |
ub ub | 10 |
electron density | 10 |
postweaning multisystemic | 10 |
time course | 10 |
unpublished data | 10 |
virus life | 10 |
infection remains | 10 |
virological study | 10 |
length nsp | 10 |
relative levels | 10 |
iii interferons | 10 |
related genes | 10 |
rad expressing | 10 |
coronavirus infectious | 10 |
prrsv genotype | 10 |
replicase polyprotein | 10 |
associated protein | 10 |
essential role | 10 |
recent advances | 10 |
protein modulates | 10 |
type infection | 10 |
mm kcl | 10 |
reduced levels | 10 |
nature remains | 10 |
pigs exhibited | 10 |
prrsv induced | 10 |
attenuated vaccines | 10 |
signal peptide | 10 |
per million | 10 |
campylobacter jejuni | 10 |
agarose beads | 10 |
genome sequence | 10 |
active immunity | 10 |
genome organization | 10 |
dna viruses | 10 |
mutation rate | 10 |
modified eagle | 10 |
expression analysis | 10 |
viral epitopes | 10 |
analysis showed | 10 |
prrsv neutralizing | 10 |
cd receptor | 10 |
remains neutral | 10 |
channel protein | 10 |
five pigs | 10 |
virus replicates | 10 |
vrp expressing | 10 |
also includes | 10 |
high mutation | 10 |
lymphoid follicles | 10 |
coinfected groups | 10 |
induced cpe | 10 |
elevated levels | 10 |
arch virol | 10 |
springer nature | 10 |
reduced ability | 10 |
may help | 10 |
serum igg | 10 |
northern blot | 10 |
glycoproteins gp | 10 |
interfering rna | 10 |
enhanced ifn | 10 |
adult animals | 10 |
three washes | 10 |
red blood | 10 |
tumor domain | 10 |
sentinel pigs | 10 |
time intervals | 10 |
may induce | 10 |
upper panels | 10 |
pigs remained | 10 |
prrsv causes | 10 |
genotype porcine | 10 |
airway resistance | 10 |
national research | 10 |
digital gene | 10 |
target cell | 10 |
flow cytometric | 10 |
commercial porcine | 10 |
total cell | 10 |
rtgev vector | 10 |
institutional affiliations | 10 |
length polymorphism | 10 |
catalytic triad | 10 |
cellular targets | 10 |
viral gene | 10 |
conserved sequence | 10 |
proinflammatory cytokine | 10 |
recombinant viruses | 10 |
uninfected pigs | 10 |
challenge virus | 10 |
competitor rna | 10 |
total phenolic | 10 |
small interfering | 10 |
animals showed | 10 |
mtt assay | 10 |
heavy chain | 10 |
baculovirus expression | 10 |
animal model | 10 |
control strategies | 10 |
pathological changes | 10 |
intranasal inoculation | 10 |
inhibit type | 10 |
dc macrophage | 10 |
germinal centers | 10 |
test whether | 10 |
actin gene | 10 |
flag antibody | 10 |
transmembrane domain | 10 |
right panel | 10 |
viral genomes | 10 |
memory cells | 10 |
papn knockout | 10 |
week post | 10 |
hp prrsv | 10 |
fluorescent microscope | 10 |
full protection | 10 |
future direction | 10 |
virus non | 10 |
low level | 10 |
present work | 10 |
multiparous sows | 10 |
suppressive effect | 10 |
lelystad isolate | 10 |
accession numbers | 10 |
deprived pig | 10 |
two viruses | 10 |
results show | 10 |
orf ab | 10 |
international committee | 10 |
prrsv viability | 10 |
increased susceptibility | 10 |
lower levels | 10 |
van den | 10 |
extracellular vesicles | 10 |
respiratory problems | 10 |
takes place | 10 |
dose dependent | 10 |
disease control | 10 |
commonly used | 10 |
cells compared | 10 |
inhibit viral | 10 |
serum antibody | 10 |
bars represent | 10 |
interferon induction | 10 |
pcr positive | 10 |
mutational effect | 10 |
competing interests | 10 |
confocal microscopy | 10 |
nine us | 10 |
disulfide bonds | 10 |
cd ifn | 10 |
quasispecies evolution | 10 |
iowa state | 10 |
virus replicase | 10 |
prv alone | 10 |
first time | 10 |
future vaccine | 10 |
weeks later | 10 |
boar semen | 10 |
pigs developed | 10 |
lps administrations | 10 |
cholesterol level | 10 |
polyacrylamide gel | 10 |
ctl responses | 10 |
genbank id | 10 |
functional groups | 10 |
common ancestor | 10 |
negatively regulates | 10 |
passive antibodies | 10 |
gfp nsp | 10 |
severe respiratory | 10 |
endogenous irf | 10 |
microarray analysis | 10 |
induced higher | 10 |
published maps | 10 |
promoter activity | 10 |
positive selection | 10 |
infection porcine | 10 |
pigs following | 10 |
experimental challenge | 10 |
virus expressing | 10 |
responses following | 10 |
detection system | 9 |
examined using | 9 |
spike protein | 9 |
target site | 9 |
challenged animals | 9 |
i signaling | 9 |
fever disease | 9 |
systemic immunity | 9 |
attenuated strain | 9 |
visible cpe | 9 |
play important | 9 |
viral growth | 9 |
plp mutants | 9 |
enveloped single | 9 |
rjxwn challenge | 9 |
purified virus | 9 |
cytokine gene | 9 |
serum immune | 9 |
virus comparative | 9 |
immunosuppression exacerbates | 9 |
chinese herbal | 9 |
suis type | 9 |
nsp alpha | 9 |
antiviral drug | 9 |
also used | 9 |
plasmids encoding | 9 |
transcriptional activation | 9 |
wash buffer | 9 |
specific ctl | 9 |
four groups | 9 |
plaque purification | 9 |
vaccine based | 9 |
virus genetic | 9 |
recent research | 9 |
pig population | 9 |
human siglec | 9 |
vh va | 9 |
myc epitope | 9 |
acid sequences | 9 |
protein concentrations | 9 |
cell supernatants | 9 |
including nsp | 9 |
animal experiments | 9 |
viral structural | 9 |
devastating disease | 9 |
mucosal vaccine | 9 |
porcine sp | 9 |
cysteine proteases | 9 |
lung samples | 9 |
current vaccine | 9 |
effector functions | 9 |
genetic stability | 9 |
rna reads | 9 |
ii cells | 9 |
ribavirin treatment | 9 |
virus isolated | 9 |
either prrsv | 9 |
rna interference | 9 |
severe interstitial | 9 |
leader trs | 9 |
cell wall | 9 |
macrophage recruitment | 9 |
families arteriviridae | 9 |
type virus | 9 |
relative abundance | 9 |
sequence alignments | 9 |
stat pathway | 9 |
surface receptors | 9 |
cell apoptosis | 9 |
transplacental infection | 9 |
genomic negative | 9 |
strain ch | 9 |
also called | 9 |
rabbit antibody | 9 |
studies suggest | 9 |
prrsv hun | 9 |
three major | 9 |
lactate dehydrogenaseelevating | 9 |
immune complexes | 9 |
effective vaccine | 9 |
low virulent | 9 |
virological parameters | 9 |
primary immune | 9 |
kappab activation | 9 |
four hours | 9 |
flow cytometer | 9 |
xbp mrna | 9 |
imagej software | 9 |
induce protection | 9 |
cells induced | 9 |
cholesterol levels | 9 |
following challenge | 9 |
infectious progeny | 9 |
pasteurella multocida | 9 |
agents associated | 9 |
induces autophagy | 9 |
genetically diverse | 9 |
infected pig | 9 |
mediated rig | 9 |
prime boost | 9 |
ctl epitope | 9 |
fully stable | 9 |
ampk signalling | 9 |
dimethyl sulfoxide | 9 |
cfu ml | 9 |
efficient vaccines | 9 |
acid deletion | 9 |
genes including | 9 |
virus immune | 9 |
vlp vaccine | 9 |
isolated using | 9 |
structural component | 9 |
associated disease | 9 |
prrsv resistance | 9 |
specific neutralizing | 9 |
prism software | 9 |
cytokine il | 9 |
virulence factors | 9 |
enteric pathogens | 9 |
cell growth | 9 |
stable expression | 9 |
specific endoribonuclease | 9 |
high titers | 9 |
host factor | 9 |
pathway analysis | 9 |
antigenic comparison | 9 |
hydrogen bond | 9 |
prrsv vaccination | 9 |
microplate reader | 9 |
delivery system | 9 |
antiviral agent | 9 |
may reflect | 9 |
significantly induced | 9 |
infection results | 9 |
south dakota | 9 |
different isolates | 9 |
greatly reduced | 9 |
protein fused | 9 |
antigenic regions | 9 |
gamma interferon | 9 |
congenital prrsv | 9 |
control plasmid | 9 |
heterologous strains | 9 |
two types | 9 |
mg kg | 9 |
virus capsid | 9 |
swine alveolar | 9 |
side chain | 9 |
cysteine residues | 9 |
skim milk | 9 |
homologous recombination | 9 |
lung sections | 9 |
higher level | 9 |
polyclonal antibodies | 9 |
first line | 9 |
shock protein | 9 |
critical window | 9 |
antigen uptake | 9 |
cpe development | 9 |
new group | 9 |
nsp contains | 9 |
murine hepatitis | 9 |
orf present | 9 |
essential regions | 9 |
efficient replication | 9 |
impulse oscillometry | 9 |
antiviral innate | 9 |
bor infected | 9 |
serologic response | 9 |
sucrose cushion | 9 |
continuous cell | 9 |
virus reveals | 9 |
exogenous reference | 9 |
fold lower | 9 |
mm dishes | 9 |
cleavage activities | 9 |
possesses deubiquitinating | 9 |
membrane association | 9 |
unknown etiology | 9 |
next generation | 9 |
antiviral strategies | 9 |
transcriptome response | 9 |
proteasomal degradation | 9 |
weeks old | 9 |
gp gene | 9 |
molecular probes | 9 |
nine open | 9 |
diameter dishes | 9 |
host genetics | 9 |
experimental group | 9 |
infected pam | 9 |
protein possesses | 9 |
prrsv ch | 9 |
sequencing analysis | 9 |
nucleotide sequences | 9 |
neutralization test | 9 |
also investigated | 9 |
new viral | 9 |
phylogenetic perspective | 9 |
chitosan nps | 9 |
broad range | 9 |
modulating properties | 9 |
cell lysis | 9 |
ctl response | 9 |
inhibits nf | 9 |
cell receptors | 9 |
recent years | 9 |
virus assembly | 9 |
review see | 9 |
swine oral | 9 |
remains unknown | 9 |
length genomic | 9 |
viral receptor | 9 |
gene sequences | 9 |
essential medium | 9 |
molecular evolution | 9 |
related viruses | 9 |
leukemia virus | 9 |
van gucht | 9 |
viral variants | 9 |
fluid specimens | 9 |
wt groups | 9 |
purified protein | 9 |
virus recovery | 9 |
clinical cases | 9 |
gene ontology | 9 |
negative regulation | 9 |
rna samples | 9 |
veterinary microbiology | 9 |
mice vaccinated | 9 |
examined whether | 9 |
rv vaccines | 9 |
differential type | 9 |
including viral | 9 |
innate antiviral | 9 |
bactericidal activity | 9 |
ns protein | 9 |
protein level | 9 |
inhibiting irf | 9 |
protein beta | 9 |
intestinal epithelial | 9 |
genital tract | 9 |
secondary antibodies | 9 |
beta production | 9 |
foster city | 9 |
lived plasma | 9 |
associated proteins | 9 |
rich domain | 9 |
first report | 9 |
kappab signaling | 9 |
ml well | 9 |
isolates differ | 9 |
mutant proteins | 9 |
gene sequence | 9 |
fold increase | 9 |
receptor interaction | 9 |
main target | 9 |
egg yolk | 9 |
integral membrane | 9 |
inhibited ifn | 9 |
response induced | 9 |
correlation coefficient | 9 |
prrsv infects | 9 |
productively infects | 9 |
bca protein | 9 |
control measures | 9 |
various time | 9 |
induce cross | 9 |
vaccine adjuvants | 9 |
infection model | 9 |
whole genome | 9 |
mutations within | 9 |
dehydrogenaseelevating virus | 9 |
virus particle | 9 |
site loop | 9 |
inhibit virus | 9 |
growth curve | 9 |
rna mini | 9 |
conventional rt | 9 |
current state | 9 |
prrsv attachment | 9 |
genotype ii | 9 |
specific iga | 9 |
largely blocked | 9 |
tris hcl | 9 |
also tested | 9 |
creative commons | 9 |
sirnas targeting | 9 |
swine ifn | 9 |
suis infection | 9 |
interferon activation | 9 |
also possible | 9 |
within nsp | 9 |
virology doi | 9 |
bl cells | 9 |
cytoplasmic tail | 9 |
gene product | 9 |
proteins gp | 9 |
dna virus | 9 |
immortalized porcine | 9 |
bovine viral | 9 |
murine leukemia | 9 |
protection conferred | 9 |
direct contact | 9 |
specific cell | 9 |
immunological properties | 9 |
subtype strains | 9 |
tk plasmid | 9 |
several months | 9 |
isgf complex | 9 |
vaccinated mice | 9 |
quantified using | 9 |
modulates host | 9 |
mucosal adjuvants | 9 |
nidovirus transcription | 8 |
genome sequencing | 8 |
salmonella choleraesuis | 8 |
high affinity | 8 |
vaccination strategies | 8 |
high recombination | 8 |
cells may | 8 |
infection processes | 8 |
isolation kit | 8 |
cd srcr | 8 |
mosaic vaccines | 8 |
increase susceptibility | 8 |
significantly enhanced | 8 |
virus molecular | 8 |
immune correlates | 8 |
also indicated | 8 |
genus arterivirus | 8 |
viruses including | 8 |
farm conditions | 8 |
three infected | 8 |
montanide tm | 8 |
animal welfare | 8 |
genetic manipulation | 8 |
retinoic acid | 8 |
recombinant pseudorabies | 8 |
transmembrane domains | 8 |
china agricultural | 8 |
transcription unit | 8 |
inhibits pedv | 8 |
kda protein | 8 |
eukaryotic cells | 8 |
establish persistent | 8 |
interferon response | 8 |
nucleolar localisation | 8 |
virus envelope | 8 |
expressing nsp | 8 |
rna sequencing | 8 |
nsp aa | 8 |
two weeks | 8 |
results presented | 8 |
units ml | 8 |
intracellular signaling | 8 |
cultures infected | 8 |
mucosal iga | 8 |
suppress ifn | 8 |
vr strain | 8 |
prrsv evolution | 8 |
culture infective | 8 |
stranded dna | 8 |
spectrum antiviral | 8 |
infectious doses | 8 |
muench method | 8 |
gene editing | 8 |
solution containing | 8 |
jxwn plp | 8 |
discontinuous transcription | 8 |
blocking elisa | 8 |
nucleolar proteins | 8 |
sequence motifs | 8 |
cytoplasmic domain | 8 |
infection dynamics | 8 |
proteomic analysis | 8 |
inhibit nf | 8 |
detect prrsv | 8 |
responses induced | 8 |
extracellular signal | 8 |
prrs pigs | 8 |
provide new | 8 |
prrsv control | 8 |
mm pmsf | 8 |
cdna fragments | 8 |
also induce | 8 |
porcine interferon | 8 |
parainfluenza virus | 8 |
akt signaling | 8 |
serum dilution | 8 |
first one | 8 |
antiviral function | 8 |
antigen processing | 8 |
extension pcr | 8 |
endoribonuclease inactive | 8 |
mouse secondary | 8 |
virus variants | 8 |
porcine dendritic | 8 |
peer review | 8 |
software version | 8 |
induces protective | 8 |
triandra extract | 8 |
antagonism functions | 8 |
immune signaling | 8 |
infectious viral | 8 |
genetic subtypes | 8 |
vivo experiments | 8 |
gross pathology | 8 |
virus quantification | 8 |
states swine | 8 |
viral attachment | 8 |
clean tags | 8 |
nuclear transfer | 8 |
proteins may | 8 |
using chimeric | 8 |
unknown function | 8 |
phylogenetic relationships | 8 |
shuttle plasmid | 8 |
stress response | 8 |
phylogenetic analyses | 8 |
rescued virus | 8 |
arterivirus gene | 8 |
oxide synthase | 8 |
transcription polymerase | 8 |
log fold | 8 |
viruses differ | 8 |
vaccine induces | 8 |
transforming growth | 8 |
proteins involved | 8 |
minor structural | 8 |
mm hepes | 8 |
viral persistence | 8 |
nidovirales order | 8 |
prrsv protective | 8 |
mortality rates | 8 |
host factors | 8 |
irf interaction | 8 |
prrsv pigs | 8 |
global swine | 8 |
plate reader | 8 |
among strains | 8 |
first isolated | 8 |
transcription regulatory | 8 |
two pigs | 8 |
mutant protein | 8 |
experimental design | 8 |
indicated concentrations | 8 |
type viruses | 8 |
specificity pocket | 8 |
domain iii | 8 |
standard procedures | 8 |
plasmid pcdna | 8 |
group animals | 8 |
fully resistant | 8 |
infected control | 8 |
macrophage differentiation | 8 |
prrs antibody | 8 |
cell migration | 8 |
type strains | 8 |
macrophages infected | 8 |
peripheral airway | 8 |
induce treg | 8 |
primary infection | 8 |
simple method | 8 |
genetic variability | 8 |
olot strain | 8 |
biological functions | 8 |
pcr master | 8 |
genetics analysis | 8 |
peptide binding | 8 |
distinct prrsv | 8 |
antigen expression | 8 |
open access | 8 |
like symptoms | 8 |
vaccine dose | 8 |
see table | 8 |